Beta Bionics, Inc. Liquidation Value

BBNX Other

Cash & Equivalents

$30.21M
As of 2026-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $30.21M
Total Obligations: -$30.10M
$103,000
Per share: $0.00
Period: 2026-03-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $30.21M
AR: $15.75M
Total Obligations: -$30.10M
$15.85M
Per share: $0.36
Period: 2026-03-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $30.21M
AR: $15.75M
Inventory: $23.73M
Total Obligations: -$30.10M
$39.58M
Per share: $0.89
Period: 2026-03-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$103,000$0.00
Liquid Liquidation Value$15.85M$0.36
Operating Liquidation Value$39.58M$0.89

Key Components (as of 2026-03-31)

Cash & Equivalents$30.21M
Accounts Receivable$15.75M
Inventory$23.73M
Current Liabilities$23.19M
Long-term DebtN/A
Op. Lease Liability$6.91M
Finance LeaseN/A
Shares Outstanding44.6M

Explore all 145 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$30.21M$15.75M$23.73M$2.32M$23.19MN/A$6.91MN/A
2025-12-31$31.58M$17.12M$21.72M$5.00M$30.92MN/A$7.30MN/A
2025-09-30$38.48M$11.54M$20.37M$4.46M$25.39MN/A$7.69MN/A
2025-06-30$35.08M$11.39M$17.32M$3.42M$19.49MN/A$6.69MN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-04-21 View
2025-12-31 10-K 2026-02-24 View
2025-09-30 10-Q 2025-10-28 View
2025-06-30 10-Q 2025-07-29 View
2025-03-31 10-Q 2025-05-06 View
2024-12-31 10-K 2025-03-25 View
2024-12-31 10-K/A 2025-03-28 View

Community Notes

Loading notes...

Questions

Loading questions...